The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

Share Price Information for BBGI Global Infrastructure (BBGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.40
Bid: 140.00
Ask: 140.40
Change: 2.20 (1.59%)
Spread: 0.40 (0.286%)
Open: 139.00
High: 140.40
Low: 138.00
Prev. Close: 138.20
BBGI Live PriceLast checked at -
BBGI SICAV S.A. is an Investment Trust

To provide a unique access to a global portfolio of high-quality infrastructure assets which generate stable, predictable cash flows over the life of government or government-backed contracts that typically extend to more than twenty years in length.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of pre-emption rights

4 Dec 2013 07:00

RNS Number : 6217U
Bilfinger Berger Gbl Infrstre SICAV
04 December 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, OR INTO OR FROM CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

This Announcement is for information purposes only and does not constitute an invitation to subscribe for or otherwise acquire or dispose of securities in Bilfinger Berger Global Infrastructure SICAV S.A. in any jurisdiction. The information contained in this Announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this Announcement or its accuracy or completeness, This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

Bilfinger Berger Global Infrastructure SICAV S.A.

Exercise of pre-emption rights for Southern Way (PenLink)

Further to the announcement made by Bilfinger Berger Global Infrastructure SICAV S.A. ("BBGI" or the "Company") on 19 November 2013 in relation to the Company's Placing, Open Offer and Offer for Subscription (the "Issue"), the Company has been notified by Bilfinger Group that the third party shareholder pre-emption rights in relation to the Investment Capital of one of the Pipeline Assets, namely Southern Way (PenLink) ("PenLink"), have been exercised.

It is expected that the pre-emption will cover the entire Investment Capital that the Company had proposed to acquire in Penlink. As a result, the Acquisition of the Pipeline Assets will no longer include PenLink and the adjusted Price of the remaining Pipeline Assets has been determined to be approximately £154 million pursuant to the Valuation.

 

The final size of the Issue will be determined and announced in accordance with the current timetable following the closing date for applications under the Issue.

 

Terms used in this Announcement shall have the same meaning as set out in the Prospectus.

 

 

For further information please contact:

 

BBGI Management Team Tel: +352 2634791

Frank Schramm

Duncan Ball

 

Jefferies International Limited Tel: +44 (0)20 7029 8000

Gary Gould

Alex Collins

 

Oriel Securities Limited Tel: +44 (0)20 7710 7600

Neil Winward

Tom Yeadon

 

Maitland Tel: +44 (0)20 7379 5151

Liz Morley

 

Important Information

 

This Announcement has been issued by and is the sole responsibility of the Company.

 

This announcement is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in the Company or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.

 

Any investment decision must be made exclusively on the basis of the prospectus published by the Company and any supplement thereto in connection with the admission of ordinary shares of the Company to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities.

 

Jefferies International Limited and Oriel Securities Limited (together, the Joint Sponsors) each of which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, are acting exclusively for the Company and no-one else in connection with the Issue or the matters referred to in this announcement, will not regard any other person as their respective client in relation to the Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Issue or any transaction or arrangement referred to in this announcement.

 

No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Sponsors or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

This document is not for release, publication or distribution (directly or indirectly) in or into the United States, Canada, Australia, Japan or the Republic of South Africa, to any "US person" as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act") or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. The distribution of this Announcement and the Placing, Open Offer and Offer for Subscription in certain jurisdictions may be restricted by law. No action has been taken by the Company or the Joint Sponsors that would permit an offering of the New Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company and the Joint Sponsors to inform themselves about, and to observe, such restrictions.

 

The New Shares have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction of the United States and, subject to certain exceptions, may not be offered or sold within the United States or to, or for the account or benefit of, US Persons. The Company will not be registered as an "investment company" under the Investment Company Act of 1940, and investors will not be entitled to the benefits of that Act. In addition, relevant clearances have not been, and will not be, obtained from the securities commission (or equivalent) of any province of Australia, Canada, Japan or the Republic of South Africa and, accordingly, unless an exemption under any relevant legislation or regulations is applicable, none of the New Shares may be offered, sold, transferred or delivered, directly or indirectly, in Australia, Canada, Japan or the Republic of South Africa.

 

Certain statements in this Announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. The information contained in this Announcement is subject to change without notice and neither the Company nor the Joint Sponsors assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBIBDDCGGBGXX
Date   Source Headline
8th May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSResult of AGM
25th Apr 202411:33 amRNSAnnual Financial Report for year ended 31-Dec-2023
9th Apr 20244:02 pmRNSDirector/PDMR Shareholding
4th Apr 20241:26 pmRNSDirector/PDMR Shareholding
4th Apr 202410:11 amRNSResults analysis from Kepler Trust Intelligence
2nd Apr 20243:59 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSPeriodic SFDR Disclosure
28th Mar 20247:00 amRNSAnnual Results - financial year ended 31-Dec-2023
27th Mar 20245:02 pmRNSNotice of AGM
14th Mar 20247:00 amRNSRetail Investor Results - Investor Meet Company
26th Feb 20247:00 amRNSDate of Annual Results
15th Feb 20247:00 amRNSSecond Interim Dividend
9th Feb 20247:00 amRNSGrant of Share Awards under LTIP
31st Jan 20243:59 pmRNSDirectorate Change
12th Dec 20232:48 pmRNSDirector/PDMR Shareholding
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20239:52 amRNSDirector/PDMR Shareholding
4th Dec 202310:23 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSKepler Trust Intelligence: New Research
28th Nov 20234:09 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSDirectorate Change
27th Oct 20239:59 amRNSHolding(s) in Company
29th Sep 202310:02 amRNSTotal Voting Rights
29th Sep 20239:58 amRNSHolding(s) in Company
12th Sep 20233:26 pmRNSHalf-year Report
4th Sep 20237:00 amRNSSubstantial Completion Achieved On Highway 104
31st Aug 20237:00 amRNSDividend Declaration
31st Aug 20237:00 amRNSAdditional Listing
31st Aug 20237:00 amRNSHalf-year Report
16th Aug 20237:00 amRNSNotice of Interim Results and Results Presentation
13th Jul 20231:32 pmRNSHolding(s) in Company
30th Jun 20233:50 pmRNSDisclosure re SFDR
20th Jun 20234:50 pmRNSDirector/PDMR Shareholding
12th Jun 20237:50 amRNSPublication of 2022 ESG Report
1st Jun 20238:29 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSKepler Trust Intelligence: New Research
31st May 20232:36 pmRNSTotal Voting Rights
26th May 202310:07 amRNSAdditional Listing
10th May 202310:55 amRNSAnnual Financial Report for year ended 31 Dec 2022
28th Apr 20233:13 pmRNSTotal Voting Rights
28th Apr 20231:46 pmRNSResult of AGM
26th Apr 20232:25 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSAdditional Listing
30th Mar 20237:00 amRNSAnnual Results financial year ended 31-Dec-2022
28th Mar 20231:58 pmRNSNotice of AGM
3rd Mar 20234:34 pmRNSScrip Dividend Circular
16th Feb 20237:00 amRNSDividend Declaration
7th Feb 20237:00 amRNSDate of Annual Results
2nd Feb 20237:00 amRNSGrant of Share Awards under LTIP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.